Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Lux Digital Health Solutions ETF

21.98
+0.19260.88%
Post-market: 21.980.00000.00%16:15 EDT
Volume:570
Turnover:12.51K
Market Cap:4.40M
PE:- -
High:22.09
Open:22.09
Low:21.83
Close:21.79
52wk High:22.62
52wk Low:15.74
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.11
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dexcom Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS
·
Jul 31

Dexcom Inc : Jefferies Raises Target Price to $115 from $112

THOMSON REUTERS
·
Jul 31

Dexcom Inc : JP Morgan Raises Target Price to $82 from $65

THOMSON REUTERS
·
Jul 31

Dexcom Raises Annual Revenue Forecast on Strong Demand for Glucose Monitors

Reuters
·
Jul 31

Guardant Health files automatic mixed securities shelf

TIPRANKS
·
Jul 31

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS
·
Jul 31

Gartner Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

Dexcom Reports Higher Profit, Raises FY Sales Outlook

Dow Jones
·
Jul 31

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live
·
Jul 31

Dexcom Q2 FY26 GAAP Net Income Rises 39% to $249.1 Million; Revenue Climbs 13% to $1.31 Billion

Reuters
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Dexcom Inc Shares Rise 4.7% After the Bell Following Results

THOMSON REUTERS
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings
·
Jul 31

Dexcom Shares Rise 4.6% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.61

Reuters
·
Jul 31

Dexcom Outlook FY Revenue USD 5,180-5,250 Million

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted Gross Profit USD 838.5 Million

THOMSON REUTERS
·
Jul 31